SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Gold Price Monitor
GDXJ 98.59-2.8%Nov 13 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rarebird who wrote (57824)9/2/2000 4:15:09 PM
From: goldsnow  Read Replies (1) of 116759
 
Despite these woes, politicians insist on "saving Medicare." For example, President Clinton and most in Congress stand ready to dump huge chunks of projected budget surpluses over the coming 15 years into Medicare. This amounts to a massive de facto tax increase assuming that budget surpluses should be returned to the taxpayers. Medicare would not be reformed in the least.
Instead, the latest craze is to expand Medicare coverage to prescription drugs. It is worth noting that, as of 1997, private funding covered 85.3 percent of national expenditures on drugs and other medical nondurables, versus 94.5 percent in 1970. Meanwhile, private out-of-pocket payments over this period dropped from 89 percent to 48.7 percent. The continuing relatively high level of private financing is positive, but the dramatic drop in out-of-pocket payments serves as a warning.
If government moves in to pick up much of the tab for prescription drugs, the third-party payment problem will worsen, leading to higher costs not only for taxpayers but also for all health care consumers. Government price controls and restricted choice would be inevitable.


washtimes.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext